Your daily healthcare intelligence briefing. Every 24 hours — global health breakthroughs, research frontiers, entrepreneurship signals, and business opportunities curated for the research-driven medical entrepreneur.
Every day, this page receives a fresh edition — a curated newspaper-style briefing covering everything that happened in global healthcare in the last 24 hours. From clinical breakthroughs to regulatory shifts, from startup funding rounds to AI-in-medicine innovations. Each edition also includes actionable entrepreneurship angles and business ideas derived from the day's developments.
Latest published papers, clinical trial results, and breakthrough studies from top journals.
Drug approvals, pipeline updates, FDA decisions, and regulatory shifts.
Machine learning applications, diagnostic AI tools, digital health platforms, and healthtech innovations.
Venture capital deals, startup launches, IPOs, and M&A activity in healthcare.
Government initiatives, WHO updates, pandemic preparedness, and insurance ecosystem changes.
Business ideas, market gaps, whitespace analysis, and monetization frameworks extracted from the day's news.
Browse past editions of RenovaMed Daily.
For Doctors Who Think Beyond the Clinic
Editor-in-Chief: Dr. Sandeep Shrivastva (@medpreneurs)
"For Doctors Who Think Beyond the Clinic"
Edition #12 | August 12, 2026
Edition #11 | August 11, 2026
For Doctors Who Think Beyond the Clinic
For Doctors Who Think Beyond the Clinic
The Premium Healthcare Entrepreneurship Edition
Analyzing $2 Billion in market movements over the last 24 hours. We find the gaps so you can build the solutions.
Premium Healthcare Entrepreneurship Intelligence. Spotting Gaps. Building Unicorns.
For Doctors Who Think Beyond the Clinic
The landscape of medical entrepreneurship is undergoing a violent structural realignment. The first half of 2026 has definitively proven that the era of speculative, zero-revenue digital health experi...
From the FDA's landmark approval of Lutetium Lu 177 vipivotide tetraxetan for earlier-stage prostate cancer to the critical intercontinental expansion of Mpox Clade Ib, this edition captures a pivotal...
Discussion — RenovaMed Daily
Share your insights on today's developments or suggest topics for future editions.